Comparative in vitro activity of the new macrolide A-56268 against anaerobic bacteria.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001421:Bacteria, Anaerobic / Q000187:drug effects*; D002439:Cefotaxime / Q000494:pharmacology; D002440:Cefoxitin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D017291:Clarithromycin; D002981:Clindamycin / Q000494:pharmacology; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D008826:Microbial Sensitivity Tests
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D004917:Erythromycin; D002701:Chloramphenicol; D002440:Cefoxitin; D000667:Ampicillin; D017291:Clarithromycin; D002439:Cefotaxime